Healthcare
Visualizing the World’s Biggest Pharmaceutical Companies
Who are the World’s Biggest Pharmaceutical Companies?
Some of the world’s biggest pharmaceutical companies have played a central role in the COVID-19 pandemic.
However, it’s likely no surprise that the pandemic has also been great for many healthcare businesses. In fact, in 2020 alone, the world’s 50 largest pharmaceutical companies still combined for a whopping $851 billion in revenues.
In this graphic, using data from Companies Market Cap, we list the largest pharmaceutical companies in the world by market capitalization. It’s worth noting this list also includes healthcare companies that work closely with pharmaceuticals, including biotech, pharmaceutical retailers, clinical laboratories, etc.
Editor’s Note: A previous version of this graphic was missing some key companies such as GSK and AbbVie. They were unfortunately not included in the original source and we are now working to make sure there were no other smaller omissions. Thanks to all that sent in corrections.
The Pharmaceutical Leaders
To start, here are the top five biggest pharmaceutical companies in the world at the moment by market capitalization:
1. Johnson & Johnson
The pharmaceutical and consumer goods giant is worth $428.7 billion in market cap. They developed the third vaccine authorized for use in the U.S. and were named among the TIME100 Most Influential Companies List in 2021.
2. Roche
The Swiss pharmaceutical giant is at the forefront of oncology, immunology, infectious diseases, ophthalmology, and neuroscience. In 2019, Roche’s pharma segment sales rose by a healthy 16% to $53 billion.
3. Pfizer
Despite being the leading COVID-19 vaccine manufacturer in North America, Pfizer slid in the rankings to third place. The company has recently gained momentum, especially in the past quarter, with Q2’2021 revenues of $19.0 billion, reflecting a 86% operational growth from 2020.
4. Eli Lilly
Eli Lilly has taken a significant step towards establishing itself as a pharmaceutical industry leader. Having a market cap value of $125 billion in 2019, Eli Lilly has jumped to a current value of $214.9 billion, a significant growth of 72%.
5. Novartis
The second-biggest pharmaceutical company out of Switzerland, Novartis has been the face of the pharma industry for about 25 years. The primary manufacturer for the most recognizable drugs on the market pulled in a revenue of over $48 billion in 2020, a 3% increase compared to 2019.
Here’s how all the biggest pharmaceutical companies in the world stack up against each other:
Company Rank | Company Name | Market Cap Value | Country |
---|---|---|---|
1 | Johnson & Johnson JNJ | $428.66 B | 🇺🇸 USA |
2 | Roche RHHBY | $320.41 B | 🇨🇭 Switzerland |
3 | Pfizer PFE | $219.39 B | 🇺🇸 USA |
4 | Eli Lilly LLY | $208.99 B | 🇺🇸 USA |
5 | Novartis NVS | $207.70 B | 🇨🇭 Switzerland |
6 | AbbVie ABBV | $202.60 B | 🇺🇸 USA |
7 | Merck MRK | $191.67 B | 🇺🇸 USA |
8 | Novo Nordisk NVO | $187.83 B | 🇩🇰 Denmark |
9 | Astrazeneca AZN | $152.28 B | 🇬🇧 UK |
10 | Bristol-Myers Squibb BMY | $145.80 B | 🇺🇸 USA |
11 | Amgen AMGN | $136.50 B | 🇺🇸 USA |
12 | Sanofi SNY | $130.37 B | 🇫🇷 France |
13 | CVS Health CVS | $110.49 B | 🇺🇸 USA |
14 | GlaxoSmithKline GSK | $104.30 B | 🇬🇧 UK |
15 | CSL CSL.AX | $103.10 B | 🇦🇺 Australia |
16 | Gilead Sciences GILD | $83.62 B | 🇺🇸 USA |
17 | Moderna MRNA | $83.25 B | 🇺🇸 USA |
18 | Merck KGaA MRK.DE | $80.61 B | 🇩🇪 Germany |
19 | Bayer BAYZF | $59.43 B | 🇩🇪 Germany |
20 | Jiangsu Hengrui Medicine 600276.SS | $58.51 B | 🇨🇳 China |
21 | Regeneron Pharmaceuticals REGN | $55.83 B | 🇺🇸 USA |
22 | Biogen BIIB | $55.00 B | 🇺🇸 USA |
23 | BioNTech BNTX | $54.23 B | 🇩🇪 Germany |
24 | Takeda Pharmaceutical TAK | $52.67 B | 🇯🇵 Japan |
25 | Lonza LONN.SW | $52.16 B | 🇨🇭 Switzerland |
26 | Walgreens Boots Alliance WBA | $45.05 B | 🇺🇸 USA |
27 | Celltrion 068270.KS | $33.80 B | 🇰🇷 S. Korea |
28 | Astellas Pharma ALPMF | $33.42 B | 🇯🇵 Japan |
29 | BeiGene BGNE | $31.65 B | 🇨🇳 China |
30 | Eisai 4523.T | $31.20 B | 🇯🇵 Japan |
31 | West Pharma WST | $26.59 B | 🇺🇸 USA |
32 | Hansoh Pharma 3692.HK | $26.00 B | 🇨🇳 China |
33 | LabCorp LH | $25.97 B | 🇺🇸 USA |
34 | Otsuka Holdings 4578.T | $23.15 B | 🇯🇵 Japan |
35 | Horizon Therapeutics HZNP | $21.13 B | 🇮🇪 Ireland |
36 | Alnylam Pharmaceuticals ALNY | $20.42 B | 🇺🇸 USA |
37 | kyowa Kirin 4151.T | $18.85 B | 🇯🇵 Japan |
38 | Catalent CTLT | $18.74 B | 🇺🇸 USA |
39 | Sino Biopharmaceutical 1177.HK | $18.48 B | 🇭🇰 Hong Kong |
40 | Bio-Techne TECH | $17.25 B | 🇺🇸 USA |
41 | PPD PPD | $16.26 B | 🇺🇸 USA |
42 | Argenx ARGX | $16.03 B | 🇳🇱 Netherlands |
43 | Shionogi 4507.T | $15.29 B | 🇯🇵 Japan |
44 | Dr. Reddy's RDY | $11.88 B | 🇮🇳 India |
45 | Teva Pharmaceutical Industries TEVA | $11.21 B | 🇮🇱 Israel |
46 | Ono Pharmaceutical 4528.T | $11.12 B | 🇯🇵 Japan |
47 | ICON plc ICLR | $11.09 B | 🇮🇪 Ireland |
48 | Bausch Health BHC | $10.47 B | 🇨🇦 Canada |
49 | CRISPR Therapeutics CRSP | $10.42 B | 🇨🇭 Switzerland |
50 | Curevac CVAC | $10.33 B | 🇩🇪 Germany |
51 | Hualan Biological Engineering 002007.SZ | $10.31 B | 🇨🇳 China |
52 | Vifor Pharma VIFN.SW | $9.49 B | 🇨🇭 Switzerland |
53 | Neurocrine Biosciences NBIX | $9.45 B | 🇺🇸 USA |
54 | Sinopharm 1099.HK | $9.42 B | 🇨🇳 China |
55 | BridgeBio Pharma BBIO | $8.89 B | 🇺🇸 USA |
56 | Cadila Healthcare CADILAHC.NS | $8.59 B | 🇮🇳 India |
57 | Sumitomo Dainippon Pharma 4506.T | $8.16 B | 🇯🇵 Japan |
58 | Tilray TLRY | $7.89 B | 🇨🇦 Canada |
59 | Ascendis Pharma ASND | $7.51 B | 🇩🇰 Denmark |
60 | Evotec EVT.F | $7.19 B | 🇩🇪 Germany |
61 | Lupin Limited LUPIN.NS | $7.04 B | 🇮🇳 India |
62 | Gland Pharma GLAND.NS | $7.01 B | 🇮🇳 India |
63 | Exelixis EXEL | $6.95 B | 🇺🇸 USA |
64 | GW Pharmaceuticals GWPH | $6.81 B | 🇬🇧 UK |
65 | KOBAYASHI Pharmaceutical 4967.T | $6.78 B | 🇯🇵 Japan |
66 | Torrent Pharmaceuticals TORNTPHARM.NS | $6.61 B | 🇮🇳 India |
67 | Biocon BIOCON.NS | $6.43 B | 🇮🇳 India |
68 | PeptiDream 4587.T | $6.32 B | 🇯🇵 Japan |
69 | Sarepta Therapeutics SRPT | $6.25 B | 🇺🇸 USA |
70 | Perrigo PRGO | $6.21 B | 🇮🇪 Ireland |
71 | Orion Corporation ORNAV.HE | $6.11 B | 🇫🇮 Finland |
72 | Lundbeck LDB.F | $6.04 B | 🇩🇰 Denmark |
73 | AbCellera ABCL | $5.87 B | 🇨🇦 Canada |
74 | Adaptive Biotechnologies ADPT | $5.69 B | 🇺🇸 USA |
75 | Intellia Therapeutics NTLA | $5.62 B | 🇺🇸 USA |
76 | Santen Pharmaceutical 4536.T | $5.49 B | 🇯🇵 Japan |
77 | Nippon Shinyaku 4516.T | $5.46 B | 🇯🇵 Japan |
78 | Beam Therapeutics BEAM | $5.43 B | 🇺🇸 USA |
79 | Reata Pharmaceuticals RETA | $5.15 B | 🇺🇸 USA |
80 | Swedish Orphan Biovitrum SOBI.ST | $5.13 B | 🇸🇪 Sweden |
81 | BB Biotech BION.SW | $5.08 B | 🇨🇭 Switzerland |
82 | Alkem Laboratories ALKEM.NS | $5.00 B | 🇮🇳 India |
83 | Abbott India ABBOTINDIA.NS | $4.69 B | 🇮🇳 India |
84 | Laurus Labs LAURUSLABS.NS | $4.44 B | 🇮🇳 India |
85 | Taisho Pharmaceutical 4581.T | $4.39 B | 🇯🇵 Japan |
86 | Hanmi Pharmaceutical 008930.KS | $4.22 B | 🇰🇷 S. Korea |
87 | Alkermes ALKS | $3.87 B | 🇮🇪 Ireland |
88 | Karuna Therapeutics KRTX | $3.71 B | 🇺🇸 USA |
89 | Shinpoong Pharm 019170.KS | $3.65 B | 🇰🇷 S. Korea |
90 | NantKwest NK | $3.55 B | 🇺🇸 USA |
91 | Ipca Laboratories IPCALAB.NS | $3.41 B | 🇮🇳 India |
92 | Nektar Therapeutics NKTR | $3.02 B | 🇺🇸 USA |
93 | BioCryst Pharmaceuticals BCRX | $3.01 B | 🇺🇸 USA |
94 | Vericel VCEL | $2.96 B | 🇺🇸 USA |
95 | Dicerna Pharmaceuticals DRNA | $2.84 B | 🇺🇸 USA |
96 | Rocket Pharmaceuticals RCKT | $2.74 B | 🇺🇸 USA |
97 | Axsome Therapeutics AXSM | $2.65 B | 🇺🇸 USA |
98 | Natco Pharma NATCOPHARM.NS | $2.63 B | 🇮🇳 India |
99 | Alembic Pharmaceuticals APLLTD.NS | $2.59 B | 🇮🇳 India |
100 | Editas Medicine EDIT | $2.54 B | 🇺🇸 USA |
World’s Largest Pharmaceutical Exporters and Importers
According to the World Trade Organization (WTO), these countries exported the most number of pharmaceuticals in the year 2019:
Rank | Country | Export Value (US$B) |
---|---|---|
1 | 🇩🇪 Germany | $91.4 |
2 | 🇨🇭 Switzerland | $84.8 |
3 | 🇺🇸 U.S. | $55.7 |
4 | 🇧🇪 Belgium | $55.7 |
5 | 🇮🇪 Ireland | $55.4 |
In contrast, here are the biggest importers over the same period.
Rank | Country | Import Value (US$B) |
---|---|---|
1 | 🇺🇸 U.S. | $132.4 |
2 | 🇩🇪 Germany | $59.4 |
3 | 🇧🇪 Belgium | $47.3 |
4 | 🇨🇳 China | $35.7 |
5 | 🇳🇱 Netherlands | $33.5 |
This position is hardly surprising for the U.S., where six of the world’s top 10 pharmaceutical companies are headquartered. The country also captures 45% of the global market.
The Future of Pharmaceutical Companies
If the response to the COVID-19 pandemic has taught us anything, it is that in building a patient-centered future, the pharmaceutical industry plays a key role. It has to constantly find new ways to customize medicines while researching and developing new tools and drugs.
By embracing disruptive technologies like 3D printed drugs, artificial intelligence guided therapies, and preventive medicine while working with regulatory agencies, the pharmaceutical companies will benefit from having a digital revolution.
Furthermore, emerging markets will have a more significant say in the global pharmaceutical market in the coming years. Even though ‘big pharma’ will keep raking in the massive profits they do every year, their reliance on countries like Brazil and India for research and drug production will significantly impact the years to come.


The Global Syringe Shortage Threatening Vaccine Efforts
Routine vaccination saves millions of lives every single year, according to the World Health Organization (WHO).
But even though global vaccination coverage is improving, closing the gap in immunization has led to skyrocketing demand for syringes—which is forecast to result in a major shortage that could make matters worse.
In the above infographic from NuGen Medical Devices, we explore the factors leading to the syringe shortage and take a look at the company’s innovative needle-free solution that could play an important role in closing the immunization gap.
The Immunization Gap
Even before the COVID-19 pandemic, millions of people around the world struggled to get access to routine vaccinations.
In fact, as of 2019 more than 19 million children around the world were considered to be “zero-dose” which means that they did not receive any routine vaccinations.
Moreover, when the COVID-19 pandemic hit, global immunization dropped even further with 25 million children missing out on routine vaccines in 2021 alone.
Why is Immunization So Important?
Vaccinations prevent against over 20 life-threatening diseases and save between 2-3 million deaths per year, making them—as the WHO describes—the foundation of healthcare systems and an indisputable human right.

As countries work through a backlog of vaccinations to close the immunization gap that has worsened since the pandemic, demand for syringes has significantly increased.
The Result: A Global Syringe Deficit
In 2022, the WHO warned that we could see a shortage of up to 2 billion syringes if manufacturing can’t keep up. This could result in the severe disruption to routine vaccinations and promote unsafe recycling of syringes in order to administer vaccines.
But the issue goes far beyond a supply shortage of syringes. COVID-19 has brought conventional syringe vaccines into sharp focus, with many criticizing the challenges associated with them.
The Challenge | |||
Vaccine Hesitancy: 1 in 10 Americans have an extreme fear of needles and therefore will avoid vaccination. | Affordability: The cost of essential syringe vaccination makes them inaccessible for people living in low and middle income countries. | Cost of Logistics: Geographical constrains, a lack of infrastructure, and the need to keep vaccines at sub-zero temperatures prevent them from reaching those who need it the most. | Biohazardous Waste: 7.8 billion needles are discarded in the U.S. every year. |
The Solution | |||
Reduce Fear: Needle-free devices remove the fear of syringes. | Reduce Costs: Needle-free devices are lower in cost per injection compared to conventional needles. | Minimizes Cold Chain: NuGen MD’s next generation powder injectables minimize the need for a cold chain (keeping vaccines at sub-zero temperatures) entirely. | Sustainable Needles: Needle-free technology reduces environmental waste significantly. |
With conventional needles facing so many challenges, it’s no surprise that investors are taking interest in viable alternatives. What’s more, these alternatives don’t just apply to vaccinations, they can also work for people with diabetes, dentists, and pet care.
Enter Needle-free Devices from NuGen MD
Needle-free devices have the potential to bridge the gap in immunization amid the global syringe shortage, solve some of the key challenges limiting vaccine uptake, and more importantly, benefit the lives of millions of people.
How Do They Work?
NuGen’s needle-free devices use a simple spring-loaded mechanism which uses pressure to release the liquid drug and penetrate the skin. In less than one-tenth of a second, the drug is dispensed more safely and evenly compared to needle syringes. It’s also virtually painless and leaves no mark on the skin.
>>>Interested in investing in NuGen Medical Devices? To learn more about their plans to pioneer the future of needle-free drug delivery, click this link now.

-
Markets18 hours ago
Mapped: GDP Growth Forecasts by Country, in 2023
The global economy faces an uncertain future in 2023. This year, GDP growth is projected to be 2.9%—down from 3.2% in 2022.
-
Technology2 days ago
Infographic: Generative AI Explained by AI
What exactly is generative AI and how does it work? This infographic, created using generative AI tools such as Midjourney and ChatGPT, explains it all.
-
Energy3 days ago
Visualizing the Scale of Global Fossil Fuel Production
How much oil, coal, and natural gas do we extract each year? See the scale of annual fossil fuel production in perspective.
-
Technology4 days ago
Infographic: 11 Tech Trends to Watch in 2023
This infographic highlights eleven exciting areas within the world of technology worth keeping an eye on in 2023.
-
Misc7 days ago
Visualizing the Odds of Dying from Various Accidents
This infographic shows you the odds of dying from a variety of accidents, including car crashes, bee stings, and more.
-
Energy7 days ago
Visualizing U.S. Consumption of Fuel and Materials per Capita
Wealthy countries consume large amounts of natural resources per capita, and the U.S. is no exception. See how much is used per person.
-
Technology2 days ago
Infographic: Generative AI Explained by AI
-
VC+2 weeks ago
Access Our Exclusive Report and Upcoming ‘2023 Global Forecast’ Webinar on VC+
-
Markets18 hours ago
Mapped: GDP Growth Forecasts by Country, in 2023
-
Money4 weeks ago
Ranked: The World’s Wealthiest Cities, by Number of Millionaires
-
Markets2 weeks ago
Charted: The Dipping Cost of Shipping
-
Technology4 weeks ago
Timeline: The Most Important Science Headlines of 2022
-
Technology1 week ago
Ranked: The Top 50 Most Visited Websites in the World
-
Money4 weeks ago
Visualizing $65 Trillion in Hidden Dollar Debt